ENZYME CATALYSIS AND REGULATION
Molecular Characterization of the S-Adenosyl-l-methionine:3′-Hydroxy-N-methylcoclaurine 4′-O-Methyltransferase Involved in Isoquinoline Alkaloid Biosynthesis in Coptis japonica *

https://doi.org/10.1074/jbc.M002439200Get rights and content
Under a Creative Commons license
open access

S-Adenosyl-l-methionine:3′-hydroxy-N-methylcoclaurine 4′-O-methyltransferase (4′-OMT) catalyzes the conversion of 3′-hydroxy-N-methylcoclaurine to reticuline, an important intermediate in synthesizing isoquinoline alkaloids. In an earlier step in the biosynthetic pathway to reticuline, anotherO-methyltransferase,S-adenosyl-l-methionine:norcoclaurine 6-O-methyltransferase (6-OMT), catalyzes methylation of the 6-hydroxyl group of norcoclaurine. We isolated two kinds of cDNA clones that correspond to the internal amino acid sequences of a 6-OMT/4′-OMT preparation from cultured Coptis japonicacells. Heterologously expressed proteins had 6-OMT or 4′-OMT activities, indicative that each cDNA encodes a different enzyme. 4′-OMT was purified using recombinant protein, and its enzymological properties were characterized. It had enzymological characteristics similar to those of 6-OMT; the active enzyme was the dimer of the subunit, no divalent cations were required for activity, and there was inhibition by Fe2+, Cu2+, Co2+, Zn2+, or Ni2+, but none by the SH reagent. 4′-OMT clearly had different substrate specificity. It methylated (R,S)-6-O-methylnorlaudanosoline, as well as (R,S)-laudanosoline and (R,S)-norlaudanosoline. Laudanosoline, anN-methylated substrate, was a much better substrate for 4′-OMT than norlaudanosoline. 6-OMT methylated norlaudanosoline and laudanosoline equally. Further characterization of the substrate saturation and product inhibition kinetics indicated that 4′-OMT follows an ordered Bi Bi mechanism, whereas 6-OMT follows a Ping-Pong Bi Bi mechanism. The molecular evolution of these two relatedO-methyltransferases is discussed.

Cited by (0)

Published, JBC Papers in Press, May 12, 2000, DOI 10.1074/jbc.M002439200

*

This work was supported in part by Grant-in-aid B (08456172) from the Ministry of Education, Science, Sports and Culture, Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank™/EMBL Data Bank with accession number(s) (for 6-OMT) and (for 4′-OMT).

§

Present address: Pharmaceutical Research Institute, Kyowa Hakko Kogyo, 1188 Shimotogari, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8731, Japan.

Present address: Nara Institute of Science and Technology, Nara 630-0101, Japan.